- Home
- DAN vs AGIO Comparison
DAN vs AGIO Comparison
Compare DAN & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAN
- AGIO
- Stock Information
- Founded
- DAN 1904
- AGIO 2007
- Country
- DAN United States
- AGIO United States
- Employees
- DAN N/A
- AGIO N/A
- Industry
- DAN Auto Parts:O.E.M.
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- DAN Consumer Discretionary
- AGIO Health Care
- Exchange
- DAN Nasdaq
- AGIO Nasdaq
- Market Cap
- DAN 2.5B
- AGIO 2.1B
- IPO Year
- DAN N/A
- AGIO 2013
- Fundamental
- Price
- DAN $20.52
- AGIO $36.89
- Analyst Decision
- DAN Buy
- AGIO Buy
- Analyst Count
- DAN 5
- AGIO 6
- Target Price
- DAN $23.20
- AGIO $57.00
- AVG Volume (30 Days)
- DAN 1.5M
- AGIO 771.2K
- Earning Date
- DAN 10-29-2025
- AGIO 10-30-2025
- Dividend Yield
- DAN 1.91%
- AGIO N/A
- EPS Growth
- DAN N/A
- AGIO N/A
- EPS
- DAN N/A
- AGIO 11.13
- Revenue
- DAN $9,938,000,000.00
- AGIO $40,875,000.00
- Revenue This Year
- DAN N/A
- AGIO $28.19
- Revenue Next Year
- DAN N/A
- AGIO $152.14
- P/E Ratio
- DAN N/A
- AGIO $3.27
- Revenue Growth
- DAN 7.73
- AGIO 30.57
- 52 Week Low
- DAN $7.58
- AGIO $23.42
- 52 Week High
- DAN $21.40
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- DAN 62.16
- AGIO 51.38
- Support Level
- DAN $20.23
- AGIO N/A
- Resistance Level
- DAN $21.30
- AGIO $37.18
- Average True Range (ATR)
- DAN 0.48
- AGIO 1.48
- MACD
- DAN -0.07
- AGIO -1.48
- Stochastic Oscillator
- DAN 52.60
- AGIO 89.42
About DAN Dana Incorporated
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.